Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
Adriana Coracini TonácioTatiana do Nascimento PedrosaEduardo Ferreira BorbaNádia Emi AikawaSandra Gofinet PasotoJúlio Cesar Rente Ferreira FilhoMarília Mantovani Sampaio BarrosElaine Pires LeonSuzete Cleusa Ferreira Spina LombardiAlfredo Mendrone JuniorAdriana de Souza AzevedoWaleska Dias SchwarczRicardo FullerEmily Figueiredo Vieira Neves YukiMichelle Remião Ugolini LopesRosa Maria Rodrigues PereiraPercival Degrava Sampaio BarrosDanieli Castro Oliveira de AndradeAna Cristina de Medeiros RibeiroJulio Cesar Bertacini de MoraesSamuel Katsuyuki ShinjoRenata MiossiAlberto José da Silva DuarteMarta Heloisa LopesEsper Georges KallásClovis Artur Almeida da SilvaEloisa BonfáPublished in: PLoS neglected tropical diseases (2021)
This clinical trial was registered with Clinicaltrials.gov (#NCT03430388).